|
| Press Releases |
|
 |
|
| Tuesday, October 3, 2023 |
|
|
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101 |
| more info >> |
|
| Monday, August 28, 2023 |
|
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
| HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
| HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
| Monday, July 24, 2023 |
|
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
| Monday, April 17, 2023 |
|
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| more info >> |
|
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the US. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Global Sports Brand U.S. Polo Assn. Launches First Retail Store in Berlin, Germany
Jul 17, 2025 00:50 HKT/SGT
|
|
|
HK Book Fair, Sports and Leisure Expo and World of Snacks open today
Jul 16, 2025 23:49 HKT/SGT
|
|
|
Buy International Homes at the Global Property Expo, Singapore
Jul 16, 2025 23:00 HKT/SGT
|
|
|
Hong Kong Picture Book Publishing Support Programme Cultivates New Creative Forces, Eight Local Illustrators Shine on the International Stage
Jul 16, 2025 22:47 HKT/SGT
|
|
|
「香港繪本出版支援計劃」培育文創新勢力 八位本地插畫師閃耀國際舞台
Jul 16, 2025 22:33 HKT/SGT
|
|
|
U.S. Polo Assn. Celebrates Seventh Year Supporting the 2025 Outsourcing Inc. Royal Charity Polo Cup
Jul 16, 2025 22:27 HKT/SGT
|
|
|
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
Jul 16, 2025 22:27 HKT/SGT
|
|
|
Hong Kong Book Fair, Sports and Leisure Expo and World of Snacks open today
Jul 16, 2025 21:11: JST
|
|
|
International Land Alliance Unveils New Revenue Model Featuring 100 Rental Homes in Cabo Oasis
Jul 16, 2025 22:00 JST
|
|
|
Doubleview Gold Corp Provides Comprehensive Update on Its Flagship Project - the Polymetallic Hat Deposit
Jul 16, 2025 20:09 HKT/SGT
|
|
|
小黃鴨德盈於LEC全球授權展上海站舉辦新IP推介會
Jul 16, 2025 19:08 HKT/SGT
|
|
|
小黄鸭德盈于LEC全球授权展上海站举办新IP推介会
Jul 16, 2025 18:30 HKT/SGT
|
|
|
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today
Jul 16, 2025 16:00: JST
|
|
|
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today
Jul 16, 2025 15:00 HKT/SGT
|
|
|
エーザイ、抗アミロイドβ抗体レカネマブの創薬研究が「第 9 回バイオインダストリー大賞」を受賞
Jul 16, 2025 14:40: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
